Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_provenance.
- NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_assertion description "[Despite 17% to 39% of all BRCA mutation carriers having a mutation in BRCA2, no prospective study to date has evaluated the efficacy of RRSO for the prevention of breast and BRCA-associated gynecologic (ovarian, fallopian tube or primary peritoneal) cancer when BRCA2 mutation carriers are analyzed separately from BRCA1 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_provenance.
- NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_assertion evidence source_evidence_literature NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_provenance.
- NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_assertion SIO_000772 18268356 NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_provenance.
- NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_assertion wasDerivedFrom befree-20150227 NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_provenance.
- NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_assertion wasGeneratedBy ECO_0000203 NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP273223.RAQxNDh2_sLnQCjIhuAfGVzEdsakrTZCHzhqynbq-PxuU130_provenance.